These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35453346)

  • 21. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
    Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.
    Zhang HS; Zhang ZG; Du GY; Sun HL; Liu HY; Zhou Z; Gou XM; Wu XH; Yu XY; Huang YH
    J Cell Mol Med; 2019 May; 23(5):3451-3463. PubMed ID: 30809937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response.
    Sun Z; Wu T; Zhao F; Lau A; Birch CM; Zhang DD
    Mol Cell Biol; 2011 May; 31(9):1800-11. PubMed ID: 21383067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
    Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
    J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sp1 is a substrate of Keap1 and regulates the activity of CRL4A
    Siswanto FM; Oguro A; Imaoka S
    J Biol Chem; 2021; 296():100704. PubMed ID: 33895141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.
    Zhang P; Singh A; Yegnasubramanian S; Esopi D; Kombairaju P; Bodas M; Wu H; Bova SG; Biswal S
    Mol Cancer Ther; 2010 Feb; 9(2):336-46. PubMed ID: 20124447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
    Zhang DD; Lo SC; Cross JV; Templeton DJ; Hannink M
    Mol Cell Biol; 2004 Dec; 24(24):10941-53. PubMed ID: 15572695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
    Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical cysteine residues of Kelch-like ECH-associated protein 1 in arsenic sensing and suppression of nuclear factor erythroid 2-related factor 2.
    He X; Ma Q
    J Pharmacol Exp Ther; 2010 Jan; 332(1):66-75. PubMed ID: 19808700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
    Kaur G; Sharma A; Bhatnagar A
    Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
    Kanzaki H; Shinohara F; Kajiya M; Kodama T
    J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
    Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
    Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
    Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
    Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11/Eotaxin-1 as a novel NRF2 regulated gene.
    Fourtounis J; Wang IM; Mathieu MC; Claveau D; Loo T; Jackson AL; Peters MA; Therien AG; Boie Y; Crackower MA
    Respir Res; 2012 Oct; 13(1):92. PubMed ID: 23061798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases.
    Pallesen JS; Tran KT; Bach A
    J Med Chem; 2018 Sep; 61(18):8088-8103. PubMed ID: 29750408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer.
    Hill KS; McDowell A; McCorkle JR; Schuler E; Ellingson SR; Plattner R; Kolesar JM
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.